Evidence map›Paper›PMID 30200215›Full record

ReviewInternational journal of molecular sciences2018

Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer.

Stephan Paschke, Sakhavat Jafarov, Ludger Staib, Ernst-Dietrich Kreuser, Catharina Maulbecker-Armstrong, Marc Roitman, Torbjörn Holm, Curtis C Harris, Karl-Heinrich Link, Marko Kornmann

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 163 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed, 5 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 5 syntheses or guidelines pooled it, 242 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Heat-killedFrontiers in immunology · 2026
    Article
  19. Article
  20. Article

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Stephan PaschkeDepartment of General and Visceral Surgery, University Hospital Ulm, 89081 Ulm, Germany. stephan.paschke@uniklinik-ulm.de.
Sakhavat JafarovSurgical Clinic, University Hospital Duesseldorf, 40225 Duesseldorf, Germany. saxavet.jafarov@yahoo.de.ORCID 0000-0003-2398-6821
Ludger StaibResearch Group Oncology of Gastrointestinal Tumors (FOGT), University of Ulm, 89081 Ulm, Germany. l.staib@klinikum-esslingen.de.
Ernst-Dietrich KreuserResearch Group Oncology of Gastrointestinal Tumors (FOGT), University of Ulm, 89081 Ulm, Germany. ernst-d.kreuser@vodafone.de.
Catharina Maulbecker-ArmstrongDepartment of Disease Prevention, Hessian Ministry for Social Affairs, Health, and Integration, Germany and Technical High School Giessen, 35390 Wiesbaden, Germany. maulbecker@hotmail.com.
Marc RoitmanSurgical Center and Asklepios Tumor Center, Asklepios Paulinen Klinik, 65197 Wiesbaden, Germany. m.roitman@asklepios.com.
Torbjörn HolmDepartment Molecular Medicine, Coloproctology, Centre of Surgical Gastroenterology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. torbjorn.holm@sll.se.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. harrisc@mail.nih.gov.
Karl-Heinrich LinkResearch Group Oncology of Gastrointestinal Tumors (FOGT), University of Ulm, 89081 Ulm, Germany. k-h.link@asklepios.com.
Marko KornmannDepartment of General and Visceral Surgery, University Hospital Ulm, 89081 Ulm, Germany. marko.kornmann@uniklinik-ulm.de.
Universität Ulm · DEAsklepios · DEDüsseldorf University Hospital · DEGerman Cancer Society · DEKarolinska University Hospital · SENational Cancer Institute · US

Funding

Precision Medicine of CancerZIABC011492 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$23.2M
6 · The paper itself

Abstract

Colon cancer (CC) and rectal cancer (RC) are synonymously called colorectal cancer (CRC). Based on our experience in basic and clinical research as well as routine work in the field, the term CRC should be abandoned. We analyzed the available data from the literature and results from our multicenter Research Group Oncology of Gastrointestinal Tumors termed FOGT to confirm or reject this hypothesis. Anatomically, the risk of developing RC is four times higher than CC, while physical activity helps to prevent CC but not RC. Obvious differences exist in molecular carcinogenesis, pathology, surgical topography and procedures, and multimodal treatment. Therefore, we conclude that CC is not the same as RC. The term "CRC" should no longer be used as a single entity in basic and clinical research as well as other areas of classification.

Indexed as

Colonic NeoplasmsCombined Modality TherapyFemaleGenetic Predisposition to DiseaseHumansMaleMulticenter Studies as TopicOrgan SpecificityRectal NeoplasmsRisk Factorscolon cancercolorectal cancerrectal cancer

Identifiers

PMID30200215
PMCPMC6165083
OpenAlexW2889522041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.